More heparin recalled in Europe

03/25/2008 | Wall Street Journal (free content), The

France, Italy and Denmark have withdrawn batches of the blood thinner heparin and its active ingredient that are tainted or suspected of contamination. Italian drugmaker Opocrin SpA said it received tainted ingredients from China's Shenzhen Hepalink Pharmaceutical Co., which also supplies APP Pharmaceuticals -- now the sole supplier of large-dose heparin for surgery and kidney dialysis in the U.S. An FDA spokeswoman said previous tests of APP's heparin showed no contamination, and APP vowed to screen its active ingredient for contaminants.

View Full Article in:

Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA